Target intelligence / Profile preview

Non-specific reactive species and glycoxidation reactions (ROS/AGEs)

Target
ROS/AGEs
Molecular classification
Reactive species, Free radicals, Non-enzymatic chemical reactions, Other
01

Overview

Non-specific reactive species and glycoxidation reactions represent a broad category of non-enzymatic chemical processes involving reactive oxygen species (ROS), reactive nitrogen species (RNS), and the formation of advanced glycation end-products (AGEs) (Sies, 2017, PubMed). These reactions are central to the concept of oxidative and carbonyl stress, where the autoxidation of sugars and lipids leads to the irreversible modification of proteins and nucleic acids (Baynes, 1991, PubMed). While reactive species play essential roles in physiological signal transduction and immune defense at low concentrations, their chronic elevation is a primary driver of tissue damage (NIH, 2023). This damage is strongly associated with the pathogenesis of diabetic complications, atherosclerosis, and neurodegenerative diseases such as Alzheimer's (StatPearls, 2023). Therapeutic approaches targeting these processes include the use of antioxidants to scavenge free radicals and specialized inhibitors to prevent the cross-linking of proteins by AGEs (PubChem). However, drug development in this area is complicated by the lack of a single molecular target and the potential for interfering with beneficial redox-sensitive signaling pathways (PubMed).

Other names
Reactive Oxygen SpeciesReactive Nitrogen SpeciesAdvanced Glycation End-productsOxidative stressCarbonyl stressGlycationMaillard reaction
02

Mechanism of action

Free radical scavenging, inhibition of the Maillard reaction, and sequestration of reactive carbonyl species (PubMed).

03

Biological functions

Signal transductionCell deathProtein modificationImmune responseOther
04

Disease associations

DiabetesCardiovascular diseaseNeurodegenerative diseaseInflammationCancerOther
05

Safety considerations

Interference with physiological redox signaling (Sies, 2017)Potential pro-oxidant effects at high dosesPoor clinical translationSystemic toxicity of early AGE inhibitors (e.g., aminoguanidine)
06

Interacting drugs

Aminoguanidine

6 more in the full profile.

07

Biomarkers

Malondialdehyde (MDA)8-hydroxy-2'-deoxyguanosine (8-OHdG)N-epsilon-(carboxymethyl)lysine (CML)PentosidineProtein carbonylsIsoprostanes (PubMed)

Beyond the preview

Go deeper on Non-specific reactive species and glycoxidation reactions (ROS/AGEs).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Non-specific reactive species and glycoxidation reactions (ROS/AGEs).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call